|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q47504222
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010714.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q47504222
|
|
024
|
|
|
‡a
0000-0002-6094-0024
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q47504222
|
|
100
|
0 |
|
‡a
Beatriz Bosch
‡9
ast
‡9
es
‡9
sl
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Beatriz Bosch
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Beatriz Bosch
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A novel PSEN1 gene mutation
|
|
670
|
|
|
‡a
Author's A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease.
|
|
670
|
|
|
‡a
Author's A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression.
|
|
670
|
|
|
‡a
Author's APOE status modulates the changes in network connectivity induced by brain stimulation in non-demented elders
|
|
670
|
|
|
‡a
Author's Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD.
|
|
670
|
|
|
‡a
Author's Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum.
|
|
670
|
|
|
‡a
Author's Brain morphometry reproducibility in multi-center 3T MRI studies: a comparison of cross-sectional and longitudinal segmentations.
|
|
670
|
|
|
‡a
Author's Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease
|
|
670
|
|
|
‡a
Author's Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients
|
|
670
|
|
|
‡a
Author's Cerebrospinal fluid biomarkers in Alzheimer's disease families with PSEN1 mutations
|
|
670
|
|
|
‡a
Author's Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment
|
|
670
|
|
|
‡a
Author's Clinical applicability of diagnostic biomarkers in early-onset cognitive impairment
|
|
670
|
|
|
‡a
Author's Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease
|
|
670
|
|
|
‡a
Author's Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-β levels.
|
|
670
|
|
|
‡a
Author's [Cognitive reserve questionnaire. Scores obtained in a healthy elderly population and in one with Alzheimer's disease].
|
|
670
|
|
|
‡a
Author's Cognitively preserved subjects with transitional cerebrospinal fluid ß-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas.
|
|
670
|
|
|
‡a
Author's Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
|
|
670
|
|
|
‡a
Author's Decreased striatal dopamine transporter uptake in the non-fluent/agrammatic variant of primary progressive aphasia
|
|
670
|
|
|
‡a
Author's Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints
|
|
670
|
|
|
‡a
Author's [Discriminatory validity and association of the mini-mental test
|
|
670
|
|
|
‡a
Author's Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease
|
|
670
|
|
|
‡a
Author's Disease tracking markers for Alzheimer's disease at the prodromal
|
|
670
|
|
|
‡a
Author's Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
|
|
670
|
|
|
‡a
Author's Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease.
|
|
670
|
|
|
‡a
Author's Donepezil treatment stabilizes functional connectivity during resting state and brain activity during memory encoding in Alzheimer's disease.
|
|
670
|
|
|
‡a
Author's Evolving brain functional abnormalities in PSEN1 mutation carriers: a resting and visual encoding fMRI study.
|
|
670
|
|
|
‡a
Author's Evolving brain structural changes in PSEN1 mutation carriers.
|
|
670
|
|
|
‡a
Author's Functional connectivity of the hippocampus in elderly with mild memory dysfunction carrying the APOE epsilon4 allele.
|
|
670
|
|
|
‡a
Author's Greater default-mode network abnormalities compared to high order visual processing systems in amnestic mild cognitive impairment: an integrated multi-modal MRI study
|
|
670
|
|
|
‡a
Author's Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers.
|
|
670
|
|
|
‡a
Author's Interactions of cognitive reserve with regional brain anatomy and brain function during a working memory task in healthy elders.
|
|
670
|
|
|
‡a
Author's Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly
|
|
670
|
|
|
‡a
Author's Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features
|
|
670
|
|
|
‡a
Author's Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance
|
|
670
|
|
|
‡a
Author's Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects
|
|
670
|
|
|
‡a
Author's Neuroimaging and biochemical markers in the three variants of primary progressive aphasia.
|
|
670
|
|
|
‡a
Author's Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates.
|
|
670
|
|
|
‡a
Author's Normative data for the Boston Naming Test and the Pyramids and Palm Trees Test in the elderly Spanish population
|
|
670
|
|
|
‡a
Author's [Perception Digital Test (PDT) for the assessment of incipient visual disorder in initial Alzheimer's disease]
|
|
670
|
|
|
‡a
Author's Posterior cortical atrophy. Its neuropsychological profile and differences from typical Alzheimer's disease
|
|
670
|
|
|
‡a
Author's PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
|
|
670
|
|
|
‡a
Author's Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
|
|
670
|
|
|
‡a
Author's Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
|
|
670
|
|
|
‡a
Author's Specific anatomic associations between white matter integrity and cognitive reserve in normal and cognitively impaired elders
|
|
670
|
|
|
‡a
Author's [Standard values of frontal cognitive functioning tests for those over 60 years of age]
|
|
670
|
|
|
‡a
Author's Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques
|
|
670
|
|
|
‡a
Author's The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer's disease
|
|
670
|
|
|
‡a
Author's Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.
|
|
670
|
|
|
‡a
Author's Voxel based morphometry features and follow-up of amnestic patients at high risk for Alzheimer's disease conversion
|
|
670
|
|
|
‡a
Author's White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease
|
|
909
|
|
|
‡a
(orcid) 0000000260940024
‡9
1
|
|
919
|
|
|
‡a
brainmorphometryreproducibilityinmulticenter3tmristudiesacomparisonofcrosssectionalandlongitudinalsegmentations
‡A
Brain morphometry reproducibility in multi-center 3T MRI studies: a comparison of cross-sectional and longitudinal segmentations.
‡9
1
|
|
919
|
|
|
‡a
associationbetweencerebrospinalfluidtauandbrainatrophyisnotrelatedtoclinicalseverityinthealzheimersdiseasecontinuum
‡A
Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum.
‡9
1
|
|
919
|
|
|
‡a
applyingthenewresearchdiagnosticcriteriamrifindingsandneuropsychologicalcorrelationsofprodromalad
‡A
Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD.
‡9
1
|
|
919
|
|
|
‡a
apoestatusmodulatesthechangesinnetworkconnectivityinducedbybrainstimulationinnondementedelders
‡A
APOE status modulates the changes in network connectivity induced by brain stimulation in non-demented elders
‡9
1
|
|
919
|
|
|
‡a
novelpsen1mutationk239nassociatedwithalzheimersdiseasewithwiderangeageofonsetandslowprogression
‡A
A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression.
‡9
1
|
|
919
|
|
|
‡a
novelpsen1genemutationl235rassociatedwithfamilialearlyonsetalzheimersdisease
‡A
A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease.
‡9
1
|
|
919
|
|
|
‡a
novelpsen1genemutation
‡A
A novel PSEN1 gene mutation
‡9
1
|
|
919
|
|
|
‡a
cerebrospinalfluidbiomarkersinalzheimersdiseasefamilieswithpsen1mutations
‡A
Cerebrospinal fluid biomarkers in Alzheimer's disease families with PSEN1 mutations
‡9
1
|
|
919
|
|
|
‡a
cerebrospinalfluidbiomarkerspredictclinicalevolutioninpatientswithsubjectivecognitivedeclineandmildcognitiveimpairment
‡A
Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment
‡9
1
|
|
919
|
|
|
‡a
clinicalapplicabilityofdiagnosticbiomarkersinearlyonsetcognitiveimpairment
‡A
Clinical applicability of diagnostic biomarkers in early-onset cognitive impairment
‡9
1
|
|
919
|
|
|
‡a
cognitivereservemodulatestaskinducedactivationsanddeactivationsinhealthyeldersamnesticmildcognitiveimpairmentandmildalzheimersdisease
‡A
Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease
‡9
1
|
|
919
|
|
|
‡a
cognitivereserveproxiesrelatetograymatterlossincognitivelyhealthyelderlywithabnormalcerebrospinalfluidamyloidβlevels
‡A
Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-β levels.
‡9
1
|
|
919
|
|
|
‡a
cognitivereservequestionnairescoresobtainedinahealthyelderlypopulationandin1withalzheimersdisease
‡A
[Cognitive reserve questionnaire. Scores obtained in a healthy elderly population and in one with Alzheimer's disease].
‡9
1
|
|
919
|
|
|
‡a
cognitivelypreservedsubjectswithtransitionalcerebrospinalfluidssamyloid142valueshavethickercortexinalzheimersdiseasevulnerableareas
‡A
Cognitively preserved subjects with transitional cerebrospinal fluid ß-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas.
‡9
1
|
|
919
|
|
|
‡a
corticalbrainmetabolismasmeasuredbyprotonspectroscopyisrelatedtomemoryperformanceinpatientswithamnesticmildcognitiveimpairmentandalzheimersdisease
‡A
Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
‡9
1
|
|
919
|
|
|
‡a
decreasedstriataldopaminetransporteruptakeinthenonfluentagrammaticvariantofprimaryprogressiveaphasia
‡A
Decreased striatal dopamine transporter uptake in the non-fluent/agrammatic variant of primary progressive aphasia
‡9
1
|
|
919
|
|
|
‡a
differentprofilesofalzheimersdiseasecerebrospinalfluidbiomarkersincontrolsandsubjectswithsubjectivememorycomplaints
‡A
Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints
‡9
1
|
|
919
|
|
|
‡a
discriminatoryvalidityandassociationoftheminimentaltest
‡A
[Discriminatory validity and association of the mini-mental test
‡9
1
|
|
919
|
|
|
‡a
discriminatoryvalidityandassociationoftheminimentaltestmmseandthememoryalterationtestm@twithaneuropsychologicalbatteryinpatientswithamnesticmildcognitiveimpairmentandalzheimersdisease
‡A
Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease
‡9
1
|
|
919
|
|
|
‡a
diseasetrackingmarkersforalzheimersdiseaseattheprodromal
‡A
Disease tracking markers for Alzheimer's disease at the prodromal
‡9
1
|
|
919
|
|
|
‡a
diseasetrackingmarkersforalzheimersdiseaseattheprodromal1101stage
‡A
Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
‡9
1
|
|
919
|
|
|
‡a
distinctfunctionalactivityoftheprecuneusandposteriorcingulatecortexduringencodinginthepreclinicalstageofalzheimersdisease
‡A
Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease.
‡9
1
|
|
919
|
|
|
‡a
donepeziltreatmentstabilizesfunctionalconnectivityduringrestingstateandbrainactivityduringmemoryencodinginalzheimersdisease
‡A
Donepezil treatment stabilizes functional connectivity during resting state and brain activity during memory encoding in Alzheimer's disease.
‡9
1
|
|
919
|
|
|
‡a
evolvingbrainfunctionalabnormalitiesinpsen1mutationcarriersarestingandvisualencodingfmristudy
‡A
Evolving brain functional abnormalities in PSEN1 mutation carriers: a resting and visual encoding fMRI study.
‡9
1
|
|
919
|
|
|
‡a
evolvingbrainstructuralchangesinpsen1mutationcarriers
‡A
Evolving brain structural changes in PSEN1 mutation carriers.
‡9
1
|
|
919
|
|
|
‡a
functionalconnectivityofthehippocampusinelderlywithmildmemorydysfunctioncarryingtheapoeepsilon4allele
‡A
Functional connectivity of the hippocampus in elderly with mild memory dysfunction carrying the APOE epsilon4 allele.
‡9
1
|
|
919
|
|
|
‡a
greaterdefaultmodenetworkabnormalitiescomparedtohighordervisualprocessingsystemsinamnesticmildcognitiveimpairmentanintegratedmultimodalmristudy
‡A
Greater default-mode network abnormalities compared to high order visual processing systems in amnestic mild cognitive impairment: an integrated multi-modal MRI study
‡9
1
|
|
919
|
|
|
‡a
increasedcorticalthicknessandcaudatevolumeprecedeatrophyinpsen1mutationcarriers
‡A
Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers.
‡9
1
|
|
919
|
|
|
‡a
interactionsofcognitivereservewithregionalbrainanatomyandbrainfunctionduringaworkingmemorytaskinhealthyelders
‡A
Interactions of cognitive reserve with regional brain anatomy and brain function during a working memory task in healthy elders.
‡9
1
|
|
919
|
|
|
‡a
longitudinalreproducibilityofautomaticallysegmentedhippocampalsubfieldsamultisiteeuropean3tstudyonhealthyelderly
‡A
Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly
‡9
1
|
|
919
|
|
|
‡a
longitudinalstudyofamnesicpatientsathighriskforalzheimersdiseaseclinicalneuropsychologicalandmagneticresonancespectroscopyfeatures
‡A
Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features
‡9
1
|
|
919
|
|
|
‡a
multipledtiindexanalysisinnormalagingamnestic1101andadrelationshipwithneuropsychologicalperformance
‡A
Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance
‡9
1
|
|
919
|
|
|
‡a
multisitelongitudinalreliabilityoftractbasedspatialstatisticsindiffusiontensorimagingofhealthyelderlysubjects
‡A
Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects
‡9
1
|
|
919
|
|
|
‡a
neuroimagingandbiochemicalmarkersinthe3variantsofprimaryprogressiveaphasia
‡A
Neuroimaging and biochemical markers in the three variants of primary progressive aphasia.
‡9
1
|
|
919
|
|
|
‡a
neuropsychologicalprofileofprodromalalzheimersdiseaseprdadandtheirradiologicalcorrelates
‡A
Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates.
‡9
1
|
|
919
|
|
|
‡a
normativedataforthebostonnamingtestandthepyramidsandpalmtreestestintheelderlyspanishpopulation
‡A
Normative data for the Boston Naming Test and the Pyramids and Palm Trees Test in the elderly Spanish population
‡9
1
|
|
919
|
|
|
‡a
perceptiondigitaltestpdtfortheassessmentofincipientvisualdisorderininitialalzheimersdisease
‡A
[Perception Digital Test (PDT) for the assessment of incipient visual disorder in initial Alzheimer's disease]
‡9
1
|
|
919
|
|
|
‡a
posteriorcorticalatrophyitsneuropsychologicalprofileanddifferencesfromtypicalalzheimersdisease
‡A
Posterior cortical atrophy. Its neuropsychological profile and differences from typical Alzheimer's disease
‡9
1
|
|
919
|
|
|
‡a
psen1mutationcarrierspresentlowercerebrospinalfluidamyoidβ42levelsthansporadicearlyonsetalzheimersdiseasepatientsbutnodifferencesinneuronalinjurybiomarkers
‡A
PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
‡9
1
|
|
919
|
|
|
‡a
screeningforamnesticmildcognitiveimpairmentandearlyalzheimersdiseasewithm@tmemoryalterationtestintheprimarycarepopulation
‡A
Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
‡9
1
|
|
919
|
|
|
‡a
serumprogranulinlevelsinpatientswithfrontotemporallobardegenerationandalzheimersdiseasedetectionofgrnmutationsinaspanishcohort
‡A
Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
‡9
1
|
|
919
|
|
|
‡a
specificanatomicassociationsbetweenwhitematterintegrityandcognitivereserveinnormalandcognitivelyimpairedelders
‡A
Specific anatomic associations between white matter integrity and cognitive reserve in normal and cognitively impaired elders
‡9
1
|
|
919
|
|
|
‡a
standardvaluesoffrontalcognitivefunctioningtestsforthoseover60yearsofage
‡A
[Standard values of frontal cognitive functioning tests for those over 60 years of age]
‡9
1
|
|
919
|
|
|
‡a
testretestreliabilityofthedefaultmodenetworkinamulticentricfmristudyofhealthyelderlyeffectsofdatadrivenphysiologicalnoisecorrectiontechniques
‡A
Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques
‡9
1
|
|
919
|
|
|
‡a
memoryalterationtestm@tdiscriminatesbetweensubjectivememorycomplaintsmildcognitiveimpairmentandalzheimersdisease
‡A
The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer's disease
‡9
1
|
|
919
|
|
|
‡a
usefulnessofbiomarkersinthediagnosisandprognosisofearlyonsetcognitiveimpairment
‡A
Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.
‡9
1
|
|
919
|
|
|
‡a
voxelbasedmorphometryfeaturesandfollowupofamnesticpatientsathighriskforalzheimersdiseaseconversion
‡A
Voxel based morphometry features and follow-up of amnestic patients at high risk for Alzheimer's disease conversion
‡9
1
|
|
919
|
|
|
‡a
whitematterabnormalitiestrackdiseaseprogressioninpsen1autosomaldominantalzheimersdisease
‡A
White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease
‡9
1
|
|
919
|
|
|
‡a
cerebrospinalfluidbiomarkersandmemorypresentdistinctassociationsalongthecontinuumfromhealthysubjectstoadpatients
‡A
Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients
‡9
1
|
|
919
|
|
|
‡a
brainstructureandfunctionrelatedtocognitivereservevariablesinnormalagingmildcognitiveimpairmentandalzheimersdisease
‡A
Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000061217343
|
|
996
|
|
|
‡2
LC|n 81090454
|
|
996
|
|
|
‡2
NTA|427866685
|
|
996
|
|
|
‡2
DNB|1056709650
|
|
996
|
|
|
‡2
NTA|069948054
|
|
996
|
|
|
‡2
NTA|069134537
|
|
996
|
|
|
‡2
BAV|495_106527
|
|
996
|
|
|
‡2
ARBABN|000029704
|
|
996
|
|
|
‡2
NUKAT|nx2022645609
|
|
996
|
|
|
‡2
NTA|427878977
|
|
996
|
|
|
‡2
SUDOC|120680114
|
|
996
|
|
|
‡2
PLWABN|9810615037105606
|
|
996
|
|
|
‡2
BIBSYS|9047768
|
|
996
|
|
|
‡2
BNF|15023472
|
|
996
|
|
|
‡2
RERO|A022563036
|
|
996
|
|
|
‡2
BIBSYS|2114015
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Bosch, Beatriz
‡2
ISNI|0000000061217343
‡3
exact name
|
|
998
|
|
|
‡a
Bosch, Beatriz
‡2
ISNI|0000000061217343
‡3
exact name
|
|
998
|
|
|
‡a
Beatriz Bosch
‡2
ISNI|0000000061217343
‡3
exact name
|
